Esther Brandon

2.8k citations

25 papers · 1.7k indexed · h-index 17

Health, Toxicology and Mutagenesis top 2%
Pollution top 2%
Molecular Biology
Pharmacology top 1%
Plant Science top 10%

Co-authors: Jan H.M. Schellens Jos H. Beijnen Irma Meijerman Agnes G. Oomen Adriënne J.A.M. Sips Joanna Wragg Tom Van de Wiele Christian Grøn
Topics: Pharmacogenetics and Drug Metabolism (6 papers)Effects and risks of endocrine disrupting chemicals (3 papers)Drug Transport and Resistance Mechanisms (3 papers)
Cited by: Health, Toxicology and Mutagenesis Pollution Pharmacology
Journals: SHILAP Revista de lepidopterologíaThe Science of The Total Environment Food and Chemical Toxicology
Partner nations: Netherlands Spain United States

In The Last Decade

Esther Brandon

25 papers receiving 1.7k citations

Peers

Countries citing papers authored by Esther Brandon

Since Specialization

Citations

This map shows the geographic impact of Esther Brandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Brandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Brandon more than expected).

Fields of papers citing papers by Esther Brandon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Brandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Brandon. The network helps show where Esther Brandon may publish in the future.

Co-authorship network of co-authors of Esther Brandon

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Brandon. A scholar is included among the top collaborators of Esther Brandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Brandon. Esther Brandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions 2024 ·Frontiers in Pharmacology ·(unknown),(unknown),(unknown),Esther Brandon,(unknown),(unknown),Frank G. A. Jansman,(unknown),(unknown),David S. Y. Ong,Sander D. Borgsteede	2
2	Implementation of toxicokinetics in toxicity studies – Toxicokinetics of 4-methylanisole and its metabolites in juvenile and adult rats 2015 ·Regulatory Toxicology and Pharmacology ·Esther Brandon,(unknown),J.C.H. van Eijkeren,Marc Tienstra,(unknown),Elisa C.M. Tonk,Aldert H. Piersma,Peter Bos	5
3	Asian Implications of Aflatoxin and Dioxin Foodborne Chemical Exposures Based on World Health Organization Estimates 2015 ·SHILAP Revista de lepidopterología ·Herman J. Gibb,Brecht Devleesschauwer,P. Michael Bolger,Felicia Wu,Janine Ezendam,Julie Cliff,Marco J. Zeilmaker,P Verger,John I. Pitt,Janis Baines,G. O. Adegoke,Reza Afshari,Yan Liu,Bas Bokkers,Henk Van Loveren,Marcel Mengelers,Esther Brandon,Arie H. Havelaar,David C. Bellinger	2
4	Bioaccessibility of vitamin A, vitamin C and folic acid from dietary supplements, fortified food and infant formula 2014 ·International Journal of Food Sciences and Nutrition ·Esther Brandon,Martine Bakker,Evelien Kramer,Hans Bouwmeester,(unknown),Martin Alewijn	29
5	Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats 2014 ·Particle and Fibre Toxicology ·Liesbeth Geraets,Agnes G. Oomen,Petra Krystek,Nicklas Raun Jacobsen,Håkan Wallin,Michel Laurentie,Henny W. Verharen,Esther Brandon,Wim H. de Jong	228
6	Arsenic: bioaccessibility from seaweed and rice, dietary exposure calculations and risk assessment 2014 ·Food Additives & Contaminants Part A ·Esther Brandon,P.J.C.M. Janssen,(unknown)	50
7	Does EU legislation allow the use of the Benchmark dose (BMD) approach for risk assessment? 2013 ·Regulatory Toxicology and Pharmacology ·Esther Brandon,Astrid S. Bulder,J.G.M. van Engelen,(unknown),Wim Mennes,(unknown),Anton Rietveld,(unknown),(unknown),Gerrit Wolterink,Wout Slob,Marco J. Zeilmaker,Jos Bessems	12
8	Carry-over of pyrrolizidine alkaloids from feed to milk in dairy cows 2011 ·Food Additives & Contaminants Part A ·L.A.P. Hoogenboom,Patrick P. J. Mulder,Marco J. Zeilmaker,H.J. van den Top,G.J. Remmelink,Esther Brandon,Mirjam D. Klijnstra,Gerrit A. Meijer,R. C. Schothorst,Hans P. van Egmond	86
9	An inter-laboratory trial of the unified BARGE bioaccessibility method for arsenic, cadmium and lead in soil 2011 ·The Science of The Total Environment ·Joanna Wragg,Mark Cave,N. T. Basta,Esther Brandon,Stan W. Casteel,Sébastien Denys,Christian Grøn,Agnes G. Oomen,Kenneth J. Reimer,Karine Tack,Tom Van de Wiele	319
10	Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach 2010 ·Current Gene Therapy ·Esther Brandon,(unknown),J.C.H. van Eijkeren,Birgitte Tiesjema	11
11	Fate in digestion in vitro of several food components, including some toxic compounds coming from omega-3 and omega-6 lipids 2010 ·Food and Chemical Toxicology ·Encarnación Goicoechea,Esther Brandon,Marco Blokland,Marı́a D. Guillén	56
12	Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient HAdV-5: A Qualitative Modelling Approach 2010 ·Current Gene Therapy ·Birgitte Tiesjema,(unknown),J.C.H. van Eijkeren,Esther Brandon	14
13	Effects of probiotic bacteria on the bioaccessibility of aflatoxin B₁and ochratoxin A using anin vitrodigestion model under fed conditions 2009 ·Journal of Environmental Science and Health Part B ·Bülent Kabak,Esther Brandon,İşıl Var,Marco Blokland,Adriënne J.A.M. Sips	74
14	The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors 2008 ·Current Drug Metabolism ·Miriam N. Jacobs,Wim Janssens,Ulrike Bernauer,Esther Brandon,Sandra Coecke,Robert D. Combes,Philip D. Edwards,Andreas P. Freidig,Alexius Freyberger,Richard C. Kolanczyk,(unknown),Ovanes Mekenyan,P. Schmieder,Timothy Schrader,Masahiro Takeyoshi,Bart van der Burg	43
15	In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug 2006 ·Investigational New Drugs ·Esther Brandon,Rolf W. Sparidans,(unknown),Irma Meijerman,Luis López Lázaro,(unknown),Jos H. Beijnen,Jan H.M. Schellens	15
16	Structure elucidation of aplidine metabolites formed in vitro by human liver microsomes using triple quadrupole mass spectrometry 2005 ·Journal of Mass Spectrometry ·Esther Brandon,(unknown),Rolf W. Sparidans,Luis López Lázaro,Albert J. R. Heck,Jos H. Beijnen,Jan H.M. Schellens	18
17	Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment 2005 ·Regulatory Toxicology and Pharmacology ·Esther Brandon,Agnes G. Oomen,C.J.M. Rompelberg,Carolien Versantvoort,J.G.M. van Engelen,Adriënne J.A.M. Sips	101
18	Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines 2005 ·Toxicology and Applied Pharmacology ·Esther Brandon,Tessa M. Bosch,Maarten J. Deenen,Rianne Levink,Dianne E. van der Wal,(unknown),Monique J. Bijl,Jos H. Beijnen,Jan H.M. Schellens,Irma Meijerman	74
19	In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis®, Trabectidin®), a novel marine anti-cancer drug 2005 ·Investigational New Drugs ·Esther Brandon,Rolf W. Sparidans,(unknown),(unknown),Irma Meijerman,Jos H. Beijnen,Jan H.M. Schellens	30
20	In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug 2004 ·Investigational New Drugs ·Esther Brandon,Rolf W. Sparidans,Irma Meijerman,(unknown),Jos H. Beijnen,Jan H.M. Schellens	17

About Esther Brandon

Esther Brandon is a scholar working on Pharmacology, Health, Toxicology and Mutagenesis and Radiological and Ultrasound Technology, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (484 citations), Pollution (400 citations) and Pharmacology (270 citations). Esther Brandon has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include Jan H.M. Schellens, Jos H. Beijnen, Irma Meijerman, Agnes G. Oomen, Adriënne J.A.M. Sips, Joanna Wragg, Tom Van de Wiele, Christian Grøn, Mark Cave and Sébastien Denys. Their work appears in journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Food and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact